Nasdaq Stockholm Welcomes SpectraCure to First North

Stockholm, December 4, 2018— Nasdaq (Nasdaq: NDAQ) announces that the trading in SpectraCure AB’s shares (short name: SPEC) will commence today on Nasdaq First North in Stockholm. SpectraCure belongs to the health care sector and is the 76^th company to be admitted to trading on Nasdaq’s Nordic markets* in 2018.

SpectraCure is focused on cancer treatment with medical systems with laser light sources and photoreactive drugs - photodynamic therapy (PDT). The treatment method is suitable for internal solid tumours of various kinds, such as prostate, pancreas, and head and neck cancer. SpectraCure is a start-up company from Lund University, founded in 2003 and headquartered in Lund, Sweden. For more information, please visit www.spectracure.se.

“The change of listing is expected to strengthen awareness of SpectraCure and attract a broader group of investors, as well as to give the company better access to both Swedish and international capital markets,” said Masoud Khayyami, CEO of SpectraCure.

”We welcome SpectraCure to Nasdaq First North,” said Adam Kostyál, SVP and Head of European Listings, Nasdaq. “SpectraCure joins our growing health care sector, and we look forward to supporting the company with the increased visibility that comes with a Nasdaq First North listing.”

SpectraCure AB has appointed G&W Fondkommission AB as the Certified Adviser.

*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.

About Nasdaq First North

Nasdaq First North is regulated as a multilateral trading facility, operated by the different exchanges within Nasdaq Nordic (Nasdaq First North Denmark is regulated as an alternative marketplace). It does not have the legal status as an EU-regulated market. Companies at Nasdaq First North are subject to the rules of Nasdaq First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market.

About Nasdaq

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 100 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to over 4,000 total listings with a market value of approximately $15 trillion. To learn more, visit business.nasdaq.com.

Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq Copenhagen A/S, Nasdaq Helsinki Ltd., Nasdaq Iceland hf., Nasdaq Riga, AS, Nasdaq Stockholm AB, Nasdaq Tallinn AS, AB Nasdaq Vilnius, Nasdaq Clearing AB and Nasdaq Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.

Cautionary Note Regarding Forward-Looking Statements

The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.